Predictors of long-term cognitive outcome in Alzheimer's disease
about
Memantine and cholinesterase inhibitors: complementary mechanisms in the treatment of Alzheimer's diseaseLong-term effect of galantamine on cognitive function in patients with Alzheimer's disease versus a simulated disease trajectory: an observational study in the clinical setting.Cognitive and affective assessment in day care versus institutionalized elderly patients: a 1-year longitudinal study.Adverse Effects of the Apolipoprotein E ε4 Allele on Episodic Memory, Task Switching and Gray Matter Volume in Healthy Young AdultsValidity, significance, strengths, limitations, and evidentiary value of real-world clinical data for combination therapy in Alzheimer's disease: comparison of efficacy and effectiveness studies.Response to cholinesterase inhibitors affects lifespan in Alzheimer's disease.Functional response to cholinesterase inhibitor therapy in a naturalistic Alzheimer's disease cohortCholinesterase inhibitors do not alter the length of stay in nursing homes among patients with Alzheimer's disease: a prospective, observational study of factors affecting survival time from admission to death.Mild versus moderate stages of Alzheimer's disease: three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy.Dose and plasma concentration of galantamine in Alzheimer's disease - clinical application.Progression of mild Alzheimer's disease: knowledge and prediction models required for future treatment strategies.The prediction of response to galantamine treatment in patients with mild to moderate Alzheimer's disease.Prediction models for assessing long-term outcome in Alzheimer's disease: a review.Cerebral White Matter Changes on Therapeutic Response to Rivastigmine in Alzheimer's Disease.Effect of the CYP2D6 and APOE Polymorphisms on the Efficacy of Donepezil in Patients with Alzheimer's Disease: A Systematic Review and Meta-Analysis.Progress in understanding variability in cognitive responses to cholinesterase inhibitor treatment.Early- versus late-onset Alzheimer's disease in clinical practice: cognitive and global outcomes over 3 years.Good rate of clinical response to cholinesterase inhibitors in mild and moderate Alzheimer's disease after three months of treatment: An open-label study.Psychotropic and anti-dementia treatment in elderly persons with clinical signs of dementia with Lewy bodies: a cross-sectional study in 40 nursing homes in Sweden.Effectiveness of switching to the rivastigmine transdermal patch from oral cholinesterase inhibitors: a naturalistic prospective study in Alzheimer's disease.Effect of APOE and CHRNA7 genotypes on the cognitive response to cholinesterase inhibitor treatment at different stages of Alzheimer's disease.Short-Term Response to Cholinesterase Inhibitors in Alzheimer's Disease Delays Time to Nursing Home Placement.Alzheimer's disease assessment scale-cognitive 11-item progression model in mild-to-moderate Alzheimer's disease trials of bapineuzumab.
P2860
Q27025207-ADB0EDE8-B02F-48D1-B862-9C97E825440DQ33596862-03E3CA03-33EC-4ED7-9A28-A34F35B21CE2Q33734012-CCB33523-776D-4135-9C50-7999E958EEB9Q33849832-030701BF-F88B-428D-81C1-FD75DEF364EDQ34156798-4FBF9891-E038-476A-B751-FDA1E4D6072DQ34233759-C06F7723-976A-4EEA-945D-6B151B522534Q34466802-5DD61DA4-E586-4F4C-B2A1-8962F8D30CC8Q36118948-7DE54C34-6FFE-43C6-8337-AA8D0324262CQ36588166-58B61F73-D1C8-46AC-B9F9-9F26DA46D2BDQ36632702-FC626596-8D2D-4188-AC21-9AF7A0A47187Q37690649-B2589285-C45A-49F4-9C20-C5C94654A656Q37691138-20439C3E-AFD7-48C6-92C9-6AAD11414A46Q38108098-441B1111-4ED5-4EB6-BB5F-29E068F70029Q38827171-19B0D3DA-1F30-43D2-AFAA-B534B5BD48A2Q38860423-DA8EBE39-9E0B-4415-BC09-D32AB5B3EFE0Q39183032-E65E66A6-169F-4A53-8731-CB3130A1FD2BQ41588156-38F77A35-76BB-4977-B96C-B60CA347BF94Q47256371-D8066FCA-B322-4BA7-8593-6877CF281778Q49901259-62412394-E275-4E54-9883-3C6EB68B1C22Q50612791-16D91B75-552D-4F0C-902D-B60087DAD5D5Q50636887-5521CBF5-7BC2-41C9-8A49-887300B35BA8Q53397893-A5619D75-0FE2-4F77-A37B-AAD5CE1A0C3DQ54942565-6E953EF3-6182-448D-9A16-EA7C176508D8
P2860
Predictors of long-term cognitive outcome in Alzheimer's disease
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Predictors of long-term cognitive outcome in Alzheimer's disease
@ast
Predictors of long-term cognitive outcome in Alzheimer's disease
@en
type
label
Predictors of long-term cognitive outcome in Alzheimer's disease
@ast
Predictors of long-term cognitive outcome in Alzheimer's disease
@en
prefLabel
Predictors of long-term cognitive outcome in Alzheimer's disease
@ast
Predictors of long-term cognitive outcome in Alzheimer's disease
@en
P2860
P356
P1476
Predictors of long-term cognitive outcome in Alzheimer's disease
@en
P2093
Asa K Wallin
Carina Wattmo
P2860
P2888
P356
10.1186/ALZRT85
P407
P577
2011-07-20T00:00:00Z
P5875
P6179
1000017499